Intellia Therapeutics, Inc. (0JBU.L) LSE

9.74

-0.0781(-0.80%)

Updated at December 05 10:19AM

Currency In USD

Valuation

Market Cap1.15B
Enterprise Value1.17B
P/E Ratio-2.41
PEG Ratio-0.27
Price/Sales Ratio17.74
Price/Book Ratio1.43
Enterprise/Revenue16.08
Enterprise/EBITDA-2.57

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-7.75
Operating Margin-6.38

Management Effectiveness

Return On Assets-0.48
Return On Equity-0.57

Income Statement

Revenue57.88M
Revenue/Share0.52
Gross Profit47.59M
EBITDA-523.98M
Net Income-519.02M
Diluted EPS-5.25

Balance Sheet

Total Cash511.04M
Total Cash/Share4.64
Total Debt97.97M
Total Debt/Equity0.13
Current Ratio6.21
Book Value Per Share6.79

Price History

52-Week Change-29.22
52-Week High46.91
52-Week Low9.74
Moving Average 50 Days27.81
Moving Average 200 Days33.27

Statistics

Average Volume3,135
Shares Outstanding104.79M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A